OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.040
-0.070 (-3.32%)
Jul 23, 2026, 4:00 PM EDT - Market closed
OmniAb Revenue
OmniAb had revenue of $14.43M in the quarter ending March 31, 2026, with 247.30% growth. This brings the company's revenue in the last twelve months to $28.94M, up 8.21% year-over-year. In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%.
Revenue (ttm)
$28.94M
Revenue Growth
+8.21%
P/S Ratio
10.22
Revenue / Employee
$325,157
Employees
89
Market Cap
295.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.67M | -7.73M | -29.27% |
| Dec 31, 2024 | 26.39M | -7.77M | -22.75% |
| Dec 31, 2023 | 34.16M | -24.91M | -42.17% |
| Dec 31, 2022 | 59.08M | 24.33M | 70.02% |
| Dec 31, 2021 | 34.75M | 11.48M | 49.34% |
| Dec 31, 2020 | 23.27M | 4.95M | 27.02% |
| Dec 31, 2019 | 18.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 157.08M |
| Bicycle Therapeutics | 63.50M |
| Foghorn Therapeutics | 28.22M |
| Sol-Gel Technologies | 18.47M |
| Lineage Cell Therapeutics | 14.78M |
| Fate Therapeutics | 6.32M |
OABI News
- 7 days ago - OmniAb to Report Second Quarter 2026 Financial Results on August 6 - Business Wire
- 10 days ago - OmniAb names Nwachuku as Chief Operating Officer - TheFly
- 10 days ago - OmniAb Names Amechi Nwachuku Chief Operating Officer - Business Wire
- 2 months ago - OmniAb reports Q1 EPS (6c), consensus (10c) - TheFly
- 2 months ago - OmniAb raises FY26 revenue view to $28M-$33M, consensus $28.0M - TheFly
- 2 months ago - OmniAb Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - OmniAb Slides: Q1 2026 - Filings
- 2 months ago - OmniAb Earnings release: Q1 2026 - Filings